FDA Approves Pfizer’s Treatment for Alopecia Areata in Adolescents

June 26th, 2023|Categories: Featured, Industry News|Tags: , , , , |

The US Food and Drug Administration (FDA) has approved Pfizer’s Litfulo (ritlecitinib) for use in adolescents with severe alopecia areata, an autoimmune condition that causes hair loss. The approval marks the first treatment for the psychologically damaging condition in teens. Positive results from a phase 2b/3 study, which included over 700 patients, supported the FDA’s decision..

Go to Top